The value of reticulocyte maturity index (RMI) as a predictor of engraftment in allogeneic peripheral blood stem cell transplantation (allo-PBSCT)

被引:0
|
作者
Yenerel, MN [1 ]
Besisik, SK [1 ]
Alpdogan, TB [1 ]
Sargin, D [1 ]
Tangun, Y [1 ]
机构
[1] Istanbul Med Sch, Div Hematol, BMT Unit, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
264
引用
收藏
页码:S74 / S74
页数:1
相关论文
共 50 条
  • [1] Thrombocytopenia in allogeneic peripheral blood stem cell transplantation (allo-PBSCT) donors.
    Besisik, SK
    Alpdogan, TB
    Yenerel, MN
    Altay, S
    Sargin, D
    Tangün, Y
    BONE MARROW TRANSPLANTATION, 1998, 21 : S115 - S115
  • [2] Allogeneic peripheral blood stem cell transplantation (allo-PBSCT) for standard-risk leukemia
    Harada, M
    Kawano, F
    Kasai, M
    Sawada, H
    Nakao, S
    Ogawa, M
    Takaku, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 213 - 213
  • [3] Allogeneic peripheral blood stem cell transplantation (allo-PBSCT) versus allogeneic bone marrow transplantation (allo-BMT):: Rapid engraftment but increased morbidity due to GVHD
    Besisik, SK
    Yenerel, MN
    Alpdogan, TB
    Yavuz, AS
    Sargin, D
    Tangün, Y
    BONE MARROW TRANSPLANTATION, 1998, 21 : S110 - S110
  • [4] Incidence and severity of GVHD in allogeneic peripheral blood stem cell transplantation (ALLO-PBSCT). Analysis of 21 patients.
    Besisik, SK
    Yenerel, MN
    Alpdogan, TB
    Sargin, D
    Tangun, Y
    BLOOD, 1997, 90 (10) : 4495 - 4495
  • [5] Allogeneic peripheral blood stem cell transplantation (allo-PBSCT) with CD34 positive selection for advanced hemopathies.
    Alegre, A
    Arranz, R
    Granda, A
    Figuera, A
    Fernandez-Villalta, MJ
    Cámara, R
    Steegman, JL
    de Soria, VG
    Alonso, A
    Rodríguez-Macías, G
    Martín, P
    Arranz, E
    Fernández-Rañada, JM
    BLOOD, 2000, 96 (11) : 336B - 336B
  • [6] Prophylactic infusions of granulocytes do not increase the risk of CMV viremia post allogeneic peripheral blood stem cell transplantation (ALLO-PBSCT).
    Vij, R
    Adkins, D
    Kaufman, R
    Goodnough, L
    Trinkhaus, K
    Brown, R
    Khoury, H
    Westervelt, P
    Abidi, M
    Dipersio, J
    BLOOD, 2000, 96 (11) : 63A - 63A
  • [7] Factors for chronic GvHD after allogeneic peripheral blood stem cell transplants (allo-PBSCT) in patients with acute leukemia (AL)
    Rocha, V
    Labopin, M
    Koc, Y
    Finke, J
    Gratwohl, A
    Fassas, A
    Schwaren, A
    Schaefer, U
    Gluckman, E
    Frassoni, F
    BONE MARROW TRANSPLANTATION, 2002, 29 : S73 - S74
  • [8] Risk factors for chronic GvHD after allogeneic peripheral blood stem cell transplants (allo-PBSCT) in patients with acute leukemia (AL).
    Rocha, V
    Labopin, M
    Koc, Y
    Finke, J
    Gratwohl, A
    Fassas, A
    Schwarer, AP
    Schaeffer, UW
    Gluckman, E
    Frassoni, F
    BLOOD, 2001, 98 (11) : 397A - 398A
  • [9] ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION (ALLO-PBSCT) IN 9 PATIENTS WITH REFRACTORY LEUKEMIA AND LYMPHOMA - POTENTIAL ADVANTAGE OF BLOOD OVER MARROW ALLOGRAFTS
    KORBLING, M
    PRZEPIORKA, D
    ENGEL, H
    VANBESIEN, K
    GIRALT, S
    ANDERSSON, B
    HUH, Y
    DEISSEROTH, A
    ANDREEFF, M
    CHAMPLIN, R
    BLOOD, 1994, 84 (10) : A396 - A396
  • [10] KINETICS OF IL-7 AND IL-15 LEVELS AFTER ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (ALLO-PBSCT) FOLLOWING HIGH-DOSE OR NONMYELOABLATIVE CONDITIONING
    De Bock, M.
    Fillet, M.
    Merville, M-P
    Gothot, A.
    Beguin, Y.
    Baron, F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S275 - S275